Cell and Gene Therapy Business Outlook: Volume 2, Issue 6
8 Sep 2022
Categories:
Cell and Gene Therapy Business Outlook
Don't miss our new twice-monthly publication dedicated to cell and gene therapy. Cell and Gene Therapy Business Outlook offers the following:
- Market Sizing and Forecasting of CAGT Markets
- Executive News Summaries
- Deals Between CAGT Companies Tracked
- Financing
- Trends in the Industry
- Important Science That Will Shape Tomorrow’s Business
- Company Profiling and Quarterly Results Summaries
- Updates on Pipelines and Important Clinical Trials
- Cell and Gene Therapy Tools
- Cell and Gene Therapy CMOs
- And More
Table of Contents
- Untitled Chapter
-
Market Analysis
-
Focus on Viral Vectors
- Overview
- Market Trends
- Market Drivers and Limiters
- Market Summary
- Competitive Landscape
-
Introduction to Viral Vectors
- Types of Viral Vectors
- Transfection and Transduction
- Viral Vector Shortages
-
Focus on Viral Vectors
-
Executive News Brief
- Recent Developments in Cell and Gene Therapy
-
Finance and Funding
- A Closer Look at Recent Investment Activity in Cell and Gene Market
-
Cell and Gene Therapy Market News and News Analysis
- BioMarin Receives Conditional Marketing Approval in the European Union for Hemophilia A Gene Therapy
- Recent CGT Deal Activity